Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions

Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions

Bibliographic Details
Main Authors:	Amee D Pandya, Dhaiwat Shukla, Supriya D Malhotra, Pankaj Patel, Sapan Pandya
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Indian Journal of Rheumatology
Online Access:	http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=3;spage=251;epage=253;aulast=Pandya

Similar Items

Correlation of disease activity score using erythrocyte sedimentation rate and C-reactive protein with clinical disease activity index in rheumatoid arthritis patients
by: Viraj Panchal, et al.
Published: (2019-01-01)

A Case Report of Rituximab Induced Angioedema
by: Dhaivat Shukla, et al.
Published: (2018-09-01)

Antiepileptic drug-induced acute psychotic disorder in a nonepileptic patient: A definite prophecy
by: Mohit Dahiya, et al.
Published: (2019-01-01)

Fusarium infection complicating rheumatic keratitis that acutely progressed to endophthalmitis during regular infusion of tocilizumab: a case report
by: Yusuke Mitsuoka, et al.
Published: (2021-05-01)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
by: Tanaka T, et al.
Published: (2014-04-01)

The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
by: Daniel H. Solomon, et al.
Published: (2021-01-01)

Cystic echinococcus of head and neck: Anaphylactic dilemma and surgical considerations
by: Phani Kumar Kuchimanchi, et al.
Published: (2019-01-01)

The importance of early identification of infusion-related reactions to monoclonal antibodies
by: Cáceres MC, et al.
Published: (2019-08-01)

New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
by: Evgeniy L'vovich Nasonov, et al.
Published: (2010-05-01)

Inhibition of the anaphylactic
by: Church, M. K.
Published: (1970)

Drug-Induced Anaphylactic Shock
by: A. V. Matveev, et al.
Published: (2020-07-01)

The untouchables
by: Avinash Jain, et al.
Published: (2021-01-01)

Acute bilateral angle closure induced by monoclonal antibody (Daratumumab) infusion
by: Aim-on Saengsirinavin, et al.
Published: (2021-06-01)

2020 Updates on tocilizumab indications for clinicians managing patients with severe acute respiratory syndrome coronavirus 2
by: Mohammed A Omair, et al.
Published: (2020-01-01)

Pathogenetic significance of the use of a humanized monoclonal antibody to the IL-6-α receptor (tocilizumab) in the treatment of immuno-inflammatory diseases
by: V. I. Mazurov, et al.
Published: (2020-07-01)

Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
by: Patrick M. Glassman, et al.
Published: (2014-03-01)

Safety profile and practical considerations of monoclonal antibody treatment
by: B. Casanova Estruch
Published: (2013-04-01)

Studies on the anti-anaphylactic activities of phosphodiesterase inhibitors
by: Ashfield, D. J.
Published: (1982)

Anaphylactic reactions in anesthetic agents
by: Evangelina Dávila Cabo de Villa
Published: (2019-04-01)

Anaphylactic Reaction to Camomile Tea
by: Christian Andres, et al.
Published: (2009-01-01)

Anaphylactic reactions in anesthetic agents
by: Evangelina Dávila Cabo de Villa
Published: (2019-04-01)

The prediction models of anaphylactic disease
by: Changwei Wu, et al.
Published: (2021-01-01)

Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
by: Jozélio Freire de Carvalho, et al.
Published: (2018-08-01)

Therapeutic management of anaphylactic shock in a mare
by: Roy, et al.
Published: (2009-10-01)

Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
by: Chayma Ladhari, et al.
Published: (2020-02-01)

Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review
by: Ju-Yang Jung, et al.
Published: (2018-12-01)

Monoclonal B-cell lymphocytosis: a brief review for general clinicians
by: Daniel Mazza Matos, et al.

Alternative Anaphylactic Routes: The Potential Role of Macrophages
by: María M. Escribese, et al.
Published: (2017-05-01)

Kiss-induced severe anaphylactic reactions
by: Atanasković-Marković Marina, et al.
Published: (2010-01-01)

Anaphylactic reaction in patient allergic to mango
by: Natalia Ukleja-Sokołowska, et al.
Published: (2018-10-01)

Is Andrographis paniculata extract and andrographolide anaphylactic?
by: Edwin Jothie Richard, et al.
Published: (2017-01-01)

ANAPHYLACTIC SHOCK CAUSED BY IOPROMIDE IN UROGRAPHY
by: Rade R Babic
Published: (2006-10-01)

Fatal anaphylactic reaction due to Basiliximab
by: Patricia Lovisolo, et al.
Published: (2017-04-01)

Fatal anaphylactic reaction during anesthesia
by: Izidor Kern, et al.
Published: (2012-01-01)

Celery – cause of severe anaphylactic shock
by: Krzysztof Pałgan, et al.
Published: (2012-03-01)

Role of cyclic nucleotides in anaphylactic shock
by: Koochek, M. H.
Published: (1980)

Anti-PrP<sup>C </sup>monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
by: Strittmatter Stephen M, et al.
Published: (2010-10-01)

Anaphylactic cardiac collapse, sudden death and the Kounis syndrome
by: N G Kounis, et al.
Published: (2014-01-01)

Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt
by: Vasco C. Romão, et al.
Published: (2015-01-01)

Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections
by: Shun Xin Wang-Lin, et al.
Published: (2018-01-01)